Lv4
440 积分 2023-08-28 加入
Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate (S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385)
3天前
已完结
Identification of inhibitors targeting HIF-2α/c-Myc by molecular docking and MM-GBSA technology
3天前
已完结
SIRT7 couples light-driven body temperature cues to hepatic circadian phase coherence and gluconeogenesis
9天前
已完结
The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma
12天前
已完结
Hypoxia-Inducible Factor 1-Alpha (HIF-1α) and Cancer: Mechanisms of Tumor Hypoxia and Therapeutic Targeting
18天前
已完结
Targeting ARPC1B Overcomes Immune Checkpoint Inhibitor Resistance in Glioblastoma by Reversing Pro-tumorigenic Macrophage Polarization
28天前
已完结
Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding
2个月前
已完结
A Dual-Target and Dual-Mechanism Design Strategy by Combining Inhibition and Degradation Together
3个月前
已完结
Global burden of primary liver cancer in 2020 and predictions to 2040
3个月前
已完结
Changing Epidemiology of Hepatocellular Carcinoma Within the United States and Worldwide
3个月前
已完结
皖公网安备34019202002308
